Skip to main content
Top
Published in: Clinical Rheumatology 3/2024

29-01-2024 | Magnetic Resonance Imaging | ORIGINAL ARTICLE

Fatty infiltration in the posterior muscles of the lower extremities as an MRI feature in antimitochondrial antibody–associated myopathy

Authors: Yuli Wang, Zhenguo Huang, Jieping Lei, Xin Lu, Sizhao Li, Guochun Wang, Sheng Xie, Lu Zhang

Published in: Clinical Rheumatology | Issue 3/2024

Login to get access

Abstract

Objective

Idiopathic inflammatory myopathy (IIM) with antimitochondrial M2 antibody (AMA-M2) has been associated with distinct clinical characteristics. In this study, we explore the magnetic resonance imaging (MRI) findings of the muscles of the lower extremities in AMA-M2-positive IIM to gain more insight.

Methods

MRI of 22 lower extremity muscles was retrospectively evaluated in 14 patients with AMA-M2-positive IIM and 37 age- and sex-matched patients with AMA-M2-negative IIM. Muscles with inflammatory edema and fatty infiltration were assessed according to the Stramare and Mercuri criteria.

Results

Patients with AMA-M2-positive IIM had significantly higher incidence of MRI involvement with fatty infiltration in five lower extremity muscles, namely the adductor magnus (AM) (13/14 VS 14/37, p < 0.001), semimembranosus (SM) (13/14 VS 17/37, p = 0.002), biceps femoris (BF) (12/14 VS 15/37, p = 0.004), soleus (13/14 VS 23/37, p = 0.041), and the medial head of the gastrocnemius (Gastroc M) (13/14 VS 17/37, p = 0.002) than patients with AMA-M2-negative IIM. Furthermore, the severity scores of fatty infiltrations of the above five muscles in AMA-M2-positive IIM were significantly higher than those in patients with AMA-M2-negative IIM (p < 0.001).

Conclusions

Severe fatty infiltrations of the AM, SM, BF, soleus, and Gastroc M in the posterior muscles of the lower extremities are dominant MRI features in our patients with AMA-M2-positive IIM. This unique muscle MRI character may be a helpful indicator in clinical practice for patients with AMA-M2-positive IIM.
Key Points
Striking involvement and prominent fatty infiltrations of five lower extremity muscles (adductor magnus, semimembranosus, biceps femoris, soleus, and the medial head of the gastrocnemius) are interesting MRI performances.
Severe fatty infiltrations in the posterior muscles of the lower extremities are dominant MRI features in AMA-M2-positive IIM.
This unique muscle MRI character may be very helpful for the diagnosis of the AMA-M2-positive IIM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tansley S, Gunawardena H (2014) The evolving spectrum of polymyositis and dermatomyositis–moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol 47(3):264–273CrossRefPubMed Tansley S, Gunawardena H (2014) The evolving spectrum of polymyositis and dermatomyositis–moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol 47(3):264–273CrossRefPubMed
2.
go back to reference Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52(1):1–19CrossRefPubMedPubMedCentral Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52(1):1–19CrossRefPubMedPubMedCentral
3.
go back to reference Uenaka T, Kowa H, Sekiguchi K, Nagata K, Ohtsuka Y, Kanda F et al (2013) Myositis with antimitochondrial antibodies diagnosed by rectus abdominis muscle biopsy. Muscle Nerve 47(5):766–768CrossRefPubMed Uenaka T, Kowa H, Sekiguchi K, Nagata K, Ohtsuka Y, Kanda F et al (2013) Myositis with antimitochondrial antibodies diagnosed by rectus abdominis muscle biopsy. Muscle Nerve 47(5):766–768CrossRefPubMed
4.
go back to reference Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L (2018) Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement. Semin Arthritis Rheum 47(4):552–556CrossRefPubMed Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L (2018) Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement. Semin Arthritis Rheum 47(4):552–556CrossRefPubMed
5.
go back to reference Maeda MH, Tsuji S, Shimizu J (2012) Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 135(Pt 6):1767–1777CrossRefPubMed Maeda MH, Tsuji S, Shimizu J (2012) Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 135(Pt 6):1767–1777CrossRefPubMed
6.
go back to reference Zhang L, Yang H, Lei J, Peng Q, Yang H, Wang G et al (2021) Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody. Semin Arthritis Rheum 51(4):741–748CrossRefPubMed Zhang L, Yang H, Lei J, Peng Q, Yang H, Wang G et al (2021) Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody. Semin Arthritis Rheum 51(4):741–748CrossRefPubMed
7.
go back to reference Minamiyama S, Ueda S, Nakashima R, Yamakado H, Sakato Y, Yamashita H et al (2020) Thigh muscle MRI findings in myopathy associated with anti-mitochondrial antibody. Muscle Nerve 61(1):81–87CrossRefPubMed Minamiyama S, Ueda S, Nakashima R, Yamakado H, Sakato Y, Yamashita H et al (2020) Thigh muscle MRI findings in myopathy associated with anti-mitochondrial antibody. Muscle Nerve 61(1):81–87CrossRefPubMed
8.
go back to reference Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol 69(12):2271–2282CrossRefPubMedPubMedCentral Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol 69(12):2271–2282CrossRefPubMedPubMedCentral
9.
go back to reference Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K et al (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 62(4):465–472CrossRefPubMed Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K et al (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 62(4):465–472CrossRefPubMed
10.
go back to reference Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E et al (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 115(4):585–599CrossRefPubMed Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E et al (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 115(4):585–599CrossRefPubMed
11.
go back to reference Mercuri E, Cini C, Pichiecchio A, Allsop J, Counsell S, Zolkipli Z et al (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 13(7–8):554–558CrossRefPubMed Mercuri E, Cini C, Pichiecchio A, Allsop J, Counsell S, Zolkipli Z et al (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 13(7–8):554–558CrossRefPubMed
12.
go back to reference Uenaka T, Kowa H, Ohtsuka Y, Seki T, Sekiguchi K, Kanda F et al (2017) Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies. Eur Neurol 78(5–6):290–295CrossRefPubMed Uenaka T, Kowa H, Ohtsuka Y, Seki T, Sekiguchi K, Kanda F et al (2017) Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies. Eur Neurol 78(5–6):290–295CrossRefPubMed
13.
14.
go back to reference Bassendine MF, Jones DE, Yeaman SJ (1997) Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis. Semin Liver Dis 17(1):49–60CrossRefPubMed Bassendine MF, Jones DE, Yeaman SJ (1997) Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis. Semin Liver Dis 17(1):49–60CrossRefPubMed
15.
16.
go back to reference Han E, Jo SJ, Lee H, Choi AR, Lim J, Jung ES et al (2017) Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clin Chim Acta 464:113–117CrossRefPubMed Han E, Jo SJ, Lee H, Choi AR, Lim J, Jung ES et al (2017) Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clin Chim Acta 464:113–117CrossRefPubMed
17.
go back to reference Gauthier GF (1969) On the relationship of ultrastructural and cytochemical features of color in mammalian skeletal muscle. Z Zellforsch Mikrosk Anat 95(3):462–482CrossRefPubMed Gauthier GF (1969) On the relationship of ultrastructural and cytochemical features of color in mammalian skeletal muscle. Z Zellforsch Mikrosk Anat 95(3):462–482CrossRefPubMed
Metadata
Title
Fatty infiltration in the posterior muscles of the lower extremities as an MRI feature in antimitochondrial antibody–associated myopathy
Authors
Yuli Wang
Zhenguo Huang
Jieping Lei
Xin Lu
Sizhao Li
Guochun Wang
Sheng Xie
Lu Zhang
Publication date
29-01-2024
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 3/2024
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-024-06877-9

Other articles of this Issue 3/2024

Clinical Rheumatology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine